Nanoblade technology: High efficiency delivery of CRISPRs components in primary cells by Virus Like Particles.

The present invention relates to a virus-derived particle comprising one or more Cas protein(s), as well as to kits and methods using the same for altering a target nucleic acid.

Keywords : CRISPR, Cas9, Virology, Gene editing, Gene therapy
Patent Application number : EP 15 306678.2 : METHODS AND PRODUCTS FOR GENETIC ENGINEERING
Patent Application date : 2015-10-20
Multidisciplinary field : -
Technology/Engineering : Gene editing
Technological Platform : -
Rare disease : -
Second indication : -
Inventors : -
Publications :
  • Efficient genome editing in primary cells and in vivo using viral-derived "Nanoblades" loaded with Cas9/sgRNA ribonucleoproteins

Related offers

The 10 Last viewed

You haven't seen any form yet.